Status:
COMPLETED
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Lead Sponsor:
Zynex Monitoring Solutions
Collaborating Sponsors:
DTarget
Conditions:
Blood Loss
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Non-invasive monitoring to measure changes in blood volume.
Eligibility Criteria
Inclusion
- Healthy volunteers
- Between 18-35 years of age
- Weight between 130-200 pounds
Exclusion
- Known cardiac disease
- Recent caffeine intake
- Tobacco use in the (4) hours prior to screening
- Infection
- Pregnancy
- Hemoglobin \<13.5 g/dl
Key Trial Info
Start Date :
June 6 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01846195
Start Date
June 6 2012
End Date
March 20 2013
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Premier Research Group
Salt Lake City, Utah, United States, 84107